CLENBUTEROL 40 - John Lee

Clenbuterol hydrochloride was originally introduced as a therapeutic agent for bronchial conditions, offering targeted stimulation of beta-2 receptors. Unlike older bronchodilators that affected both heart and lung tissues, clenbuterol’s selectivity allowed for effective airway relaxation with fewer cardiac side effects. The drug found acceptance in many European and Latin American countries but was notably never approved for human use in the United States, not due to efficacy or safety concerns, but due to the saturation of similar drugs in the American market.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CLENBUTEROL 40 by John Lee, consult with your doctor or healthcare professional.